Structure |
Chemical Name |
CAS |
MF |
 |
Trelagliptin Impurity 15 |
|
|
 |
Sofosbuvir Impurity 57 |
|
|
 |
Celecoxib Impurity 6 |
|
C17H14F3N3O2S |
 |
Emtricitabine Impurity 6 |
|
|
 |
Erlotinib Impurity 26 |
|
|
 |
Fosaprepitant Impurity 5 |
|
|
 |
Dapoxetine Impurity 5 |
1181810-25-2 |
C19H16O |
 |
Regorafenib Impurity 10 |
|
|
 |
Bosutinib Impurity 7 |
|
|
 |
Ticagrelor Impurity 12 |
|
|
 |
Ticagrelor Impurity 63 |
2227766-79-0 |
C9H9ClFN |
 |
Canagliflozin Impurity 5 |
|
|
 |
Canagliflozin Impurity 15 |
|
|
 |
Oseltamivir Impurity 31 |
|
|
 |
Riociguat IMpurtiy C |
|
|
 |
Aclidinium Bromide Impurity 1 |
|
|
 |
Ampicillin Impurity 7 |
|
|
 |
Meropenem impurity diastereomer 1 |
96035-27-7 |
C15H19N3O5S |
 |
Telmisartan tert-Butyl Ester |
144702-26-1 |
C37H38N4O2 |
 |
Amido Ethyl Meloxicam (Meloxicam Impurity) |
881399-30-0 |
C16H17N3O4S2 |
 |
Nsc249004 |
7428-39-9 |
C9H13N3O5 |
![(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/254452-86-3.gif) |
(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
254452-86-3 |
C25H24FNO4 |
 |
(E)-4-Acetoxy Tamoxifen |
76117-70-9 |
C28H31NO3 |
 |
Atorvastatin Cyclic Isopropyl Impurity |
873950-17-5 |
C33H35FN2O7 |
 |
O-Acetyl Losartan |
1006062-27-6 |
C24H25ClN6O2 |
 |
(2-Chloro-5-iodophenyl)(4-ethoxyphenyl)methanone |
1103738-26-6 |
C15H12ClIO2 |
 |
3-Dechloro-4-chloro Lamotrigine |
38943-76-9 |
C9H7Cl2N5 |
 |
D-2’-Deoxyribofuranosyl-3-guanylurea
(α/β-Mixture)
|
570410-72-9 |
C7H14N4O4 |
 |
Difluoro Atorvastatin |
693794-20-6 |
C66H66CaF4N4O10 |
 |
(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
1105067-89-7 |
C14H27NO4 |
 |
rac 5-Keto Fluvastatin |
1160169-39-0 |
C24H24FNO4 |
 |
9-Piperazino Ofloxacin |
197291-75-1 |
C18H20FN3O4 |
 |
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED |
911661-90-0 |
C21H13I6NO5 |
![(S)-Ethyl 2-((3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl)pentanoate ,95%](/CAS/GIF/129970-98-5.gif) |
(S)-Ethyl 2-((3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl)pentanoate ,95% |
129970-98-5 |
C19H30N2O4 |
 |
Exemestane Impurity A |
|
|
![(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester](/CAS/GIF/629652-44-4.gif) |
(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester |
629652-44-4 |
C22H19ClN2O5 |
 |
3-DesMorpholinyl-3-hydroxyethylaMino Gefitinib |
847949-56-8 |
C20H22ClFN4O3 |
 |
4-Deschloro-4-(2-furanylMethyl)aMino FuroseMide |
5046-19-5 |
C17H17N3O6S |
 |
Cephalexin Sulfoxide |
56193-21-6 |
C16H17N3O5S |
 |
N-Butyl Nor ScopolaMine Hydrochloride |
22235-98-9 |
C20H28ClNO4 |
 |
11β-Hydroxy Dienogest |
86153-39-1 |
C20H25NO3 |
![2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-44-6.gif) |
2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity |
116182-44-6 |
C26H43NaO9 |
 |
3-Hydroxy CitalopraM |
411221-53-9 |
C20H21FN2O2 |
 |
5-(OxiranylMethoxy)-2,3,4,9-tetrahydrocarbazole |
58457-32-2 |
C15H17NO2 |
 |
6α-Methyl Hydrocortisone 21-HeMisuccinate |
119657-85-1 |
C26H36O8 |
 |
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
 |
methyl 4-hydroxy-6-phenoxyisoquinoline-3-carboxylate |
1509958-11-5 |
C17H13NO4 |
 |
Palbociclib-012 |
2206135-30-8 |
C41H55N11O5 |
![(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone](/CAS/20211123/GIF/858127-38-5.gif) |
(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone |
858127-38-5 |
C26H32O12 |
 |
Tigecycline Impurity E |
|
|
 |
Cefminox Impurity B |
|
|
 |
isopropyl 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl) benzenesulfonate |
|
C20H19F3N2O3S |
 |
N-(2-HYDROXYETHYL)ISONICOTINAMIDE, 99 |
6265-74-3 |
C8H10N2O2 |
 |
BENAZEPRIL RELATED COMPOUND G (15 MG) ((3-(1 -ETHOXYCARBONYL-3-PHENYL-(1 S)-PROPYL)AMINO-2,3,4,5-TETRAHYDRO-2-OXO-1H-1-(3S)-BENZAZE-PINE)-1-ACETIC ACID, ETHYL ESTER) |
103129-58-4 |
C26H32N2O5 |
 |
Hydroxy Varenicline N-Trifluoroacetate |
357426-10-9 |
C15H12F3N3O2 |
 |
N2-Methyl Alfuzosin Hydrochloride |
72104-34-8 |
C19H28ClN5O4 |
 |
N2-Methyl Alfuzosin Hydrochloride |
72104-34-8 |
C19H28ClN5O4 |
 |
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |
 |
2-Fluorobiphenyl-4-carboxylic Acid |
137045-30-8 |
C13H9FO2 |
 |
Theophyllidine Hydrochloride |
116131-08-9 |
C6H10ClN4O |
 |
1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole |
887583-89-3 |
C19H20N4 |
 |
Tetracyclics compound impurities |
|
|
 |
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
 |
N'-(1-Methylazepan-4-yl)benzohydrazine |
117078-69-0 |
C14H22ClN3O |
![Ibuprofen IMp. I (EP): 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-Methylpropyl)phenyl]butyl]benzene](/) |
Ibuprofen IMp. I (EP): 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-Methylpropyl)phenyl]butyl]benzene |
|
|
![3-Quinolinecarboxylic acid, 7-[(7S)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-, hydrate](/CAS/GIF/163253-37-0.gif) |
3-Quinolinecarboxylic acid, 7-[(7S)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-, hydrate |
163253-37-0 |
C19H20ClF2N3O4 |
 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-97-7 |
C37H42F2N8O4 |
 |
4-(4-broMo-3-(hydroxyMethyl)phenoxy)benzonitrile |
906673-45-8 |
C14H10BrNO2 |
 |
ACT 080803 |
1433875-21-8 |
C16H13Br2N5O2 |
![L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 1-Methylethyl ester, (P→3'),(P'→5')-diester with (2'R)-2'-deoxy-2'-fluoro-2'-Methyluridine](/CAS/20180808/GIF/1337482-17-3.gif) |
L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 1-Methylethyl ester, (P→3'),(P'→5')-diester with (2'R)-2'-deoxy-2'-fluoro-2'-Methyluridine |
1337482-17-3 |
C34H45FN4O13P2 |
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl-](/CAS/20150408/GIF/1415560-29-0.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl- |
1415560-29-0 |
C13H13Br2N3O |
![1,1'-[1,3-Propanediylbis(oxy)]bis[2,5-dimethylbenzene]](/CAS/20150408/GIF/415724-02-6.gif) |
1,1'-[1,3-Propanediylbis(oxy)]bis[2,5-dimethylbenzene] |
415724-02-6 |
C19H24O2 |
 |
1-Dimethylamino-2-phenylbutan-2-yl 3,4,5-trimethoxybenzoate |
92414-09-0 |
C22H29NO5 |
 |
Celecoxib 2-Methyl Analog |
170569-99-0 |
C17H14F3N3O2S |
 |
EMpagliflozin iMpurity 6 |
1620758-21-5 |
C32H37ClO12 |
 |
EMpagliflozin iMpurity 11 |
|
|
![1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-](/CAS/20180629/GIF/138168-36-2.gif) |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
138168-36-2 |
C18H34N4O9 |
 |
Di-Norbudesonide (Mixture of DiastereoMers) |
1040085-98-0 |
C23H30O6 |
 |
Linagliptin MethyldiMer |
1418133-47-7 |
C50H56N16O4 |
 |
Trelagliptin Impurity isomer |
2206135-35-3 |
C18H20FN5O2 |
 |
(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C21H25ClO6 |
 |
3,6-Dichloropyrazine-2-carboxaMide |
1023813-21-9 |
C5H3Cl2N3O |
 |
N-acetic acid-1-aMino-3-adaMantanol |
1032564-18-3 |
C12H19NO3 |
 |
9(10H)-Acridinone, 2-ethoxy-6-nitro- |
451460-48-3 |
C15H12N2O4 |
 |
Olaparib iMpurity D |
|
|
 |
(5-broMo-2-chlorophenyl)(4-hydroxyphenyl)Methanone |
1360568-68-8 |
C13H8BrClO2 |
 |
(2-broMo-4,5-diMethylphenyl)Methanol |
1126385-20-3 |
C9H11BrO |
 |
Posaconazole iMpurity 8 |
|
|
 |
LCZ Impurity |
753421-85-1 |
C20H25NO2 |
 |
Dehydro Benidipine |
118935-44-7 |
C28H29N3O6 |
 |
Etoposide Impurity B |
100007-56-5 |
C29H32O13 |
 |
Istradefylline Impurity 2 |
606080-73-3 |
C20H24N4O4 |
 |
Oxonic Acid Impurity 1 |
60301-55-5 |
C3H3N3O2 |
 |
Vortioxetine Impurity 4 |
1293489-77-6 |
C18H22N2S |
 |
Zidovudine USP Impurity G |
148665-49-0 |
C20H25N7O8 |
 |
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- |
190728-24-6 |
C17H14N2O5 |
 |
Itopride Impurity A |
943518-63-6 |
C16H17NO4 |
 |
Aripiprazole N1-Oxide |
|
|
 |
Aripiprazole N1-Oxide |
|
|
 |
1-METHYL-5-MERCAPTOTETRAZOLE, SODIUM SALT |
51138-06-8 |
C2H3N4NaS |